Vor Biopharma (NASDAQ:VOR) reported quarterly losses of $(0.50) per share. This is a 99.18 percent increase over losses of $(61.23) per share from the same period last year.
Nike Has Long Runway Growth With Focus On Direct Sales, Margin Growth: Analyst React To Q4
Shares of Nike Inc (NYSE: NKE) hit a 52-week high Friday after reporting a strong fourth quarter that beat Street consensus.
Here is the reaction from analysts on the key takeaways from the earnings report and if Nike has more room to run.
